Dr. Adam Childs

Dr. Adam Childs
Dr. Childs is certified by the American Board of Urology and is a member of the American Medical Association, the American Urology Association, the Arkansas Urologic Society and the Arkansas Medical Society. Dr. Childs has special interest in the management of prostate cancer and serves on the Medical Advisory Board of the Arkansas Prostate Cancer Foundation. Dr. Childs received his medical degree from the University of Texas at Houston Medical School and was elected to the Alpha Omega Alpha medical honor society. He attended Brigham Young University and Rice University for undergraduate studies in biochemistry. After medical school, he completed his urology residency at Mayo Clinic in Rochester, Minnesota where he published multiple scientific articles and served as an instructor in urology and chief resident. Dr. Childs and his wife have four children. He is excited to now offer Aquablation Therapy to patients in the Northwest Arkansas area.
Medical School:

University of Texas at Houston Medical School

Residency:

Mayo Clinic in Rochester, Minnesota

Undergraduate:

Brigham Young University and Rice University

Locations

Arkansas Urology – Bentonville Bentonville, AR

3400 SE Macy Rd.Bentonville, Arkansas, 72712United States
479-268-6800 | Visit Website

Arkansas Urology – Fayetteville Fayetteville, Arkansas

2630 E. Citizens DriveFayetteville, Arkansas, 72703United States
479-268-6800 |

Arkansas Urology – Russellville Russellville, Arkansas

2504 W. Main StreetRussellville, Arkansas, 72801United States
479-968-2600 |

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only